Market News AIOpen the app

Arcturus Therapeutics got a $50 million investment from Meiji Seika Pharma to grow their partnership.

DealRead the original at marketscreener.com
Good for ARCT

Arcturus secured $50 million from Meiji Seika Pharma as their collaboration expands. The added funding supports the partnership, though the report gives no details on how the money will be used or what Meiji receives.

ARCT · Arcturus Therapeutics Holdings Inc.

AI read · Good for ARCT

The AI's read

The added cash can help Arcturus fund its work, and a larger collaboration strengthens its partnership. The report does not say how the money will be used or what Meiji receives, so the size of the longer-term benefit is not known.

Get alerts for ARCT

Follow Arcturus Therapeutics Holdings Inc. (ARCT) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ARCT
Free on the App Store and Google Play, or on the web.